Bulbitech
One device, a suite of rapid eye examination tests to early detect ophthalmological and neurological conditions
Bulbitech
One device, a suite of rapid eye examination tests to early detect ophthalmological and neurological conditions
Our purpose
Our aim is to screen for ophthalmological (glaucoma, AMD, nystagmus) and neurological (dementia) conditions by offering clinicians one device that can perform multiple rapid neuro-ophthalmic eye examination tests. Our unique BulbiHUB platform and BulbiCAM currently offers the user multiple tests to screen for glaucoma, age-related macular degeneration (AMD) and nystagmus. Ultimately our BulbiCAM will include multiple tests to screen for both ophthalmological and neurological conditions.
Our technology maintains good vision and cognitive health across a lifetime.
Current Tests
Visual Field test
Based on eye movement perimetry our 26-point visual field test screens the patient's visual field in 90 seconds per eye. Measuring the saccadic reaction time, an index for detection of glaucomatous visual field defects, our visual field test quantifies the reaction time towards a peripheral target and detects blind spots
Pupil test
Our pupil test, in four sequences of alternating black and white light patters, simultaneously quantifies both direct and consensual pupillary light reflex in order to detect Relative Afferent Pupil Defect (RAPD)
Ptosis test
Ptosis is a drooping or falling of the upper eyelid and can be one of the first signs of stroke, brain tumour, cancer, neurological disorders or damage to the nerves or muscles supporting the eyelid
Amsler test
Amsler is a test when doctor has suspicion on Macular Degeneration (AMD)
Worth Four Dot test
W4D is a screening test for binocularity. Often made for children.
Visual Field test
Based on eye movement perimetry our 26-point visual field test screens the patient's visual field in 90 seconds per eye. Measuring the saccadic reaction time, an index for detection of glaucomatous visual field defects, our visual field test quantifies the reaction time towards a peripheral target and detects blind spots
Pupil test
Our pupil test, in four sequences of alternating black and white light patters, simultaneously quantifies both direct and consensual pupillary light reflex in order to detect Relative Afferent Pupil Defect (RAPD)
Ptosis test
Ptosis is a drooping or falling of the upper eyelid and can be one of the first signs of stroke, brain tumour, cancer, neurological disorders or damage to the nerves or muscles supporting the eyelid
Amsler test
Amsler is a test when doctor has suspicion on Macular Degeneration (AMD)
Worth Four Dot test
W4D is a screening test for binocularity. Often made for children.
Upcoming Tests
Acuity test
Eye tracking based acuity testing is objective, doesn’t require operational assistance, and takes just 60 seconds
Nystagmus test
Nystagmus is a “wobbling eye” due to an involuntary eye movement. Nystagmus prevalence is estimated to be 24 persons in a 10.000 population. Currently there is no objective quantification of nystagmus
Strabismus test
Eye deviations are manually assessed, and subjectively interpreted. BulbiCAM will quantify the results of horizontal and vertical eye deviations
Contrast vision test
The contrast vision test is used to quantify to which degree the patient can perceive objects with low contrast. The test requires no communication with the operator. Several diseases like optic neuritis and cataract can reduce contrast vision.
Vergence test
Automated smooth vergence assessment, using virtually 3D stimulus, gives quantified data for near point of convergence and recovery including near pupil reflex
Saccade test
Performed during the visual field test our saccade test measures the peak velocity of horizontal, vertical and oblique saccades to early detect potential neurological diseases, such as Parkinson's disease, dementia or Huntington's disease
BulbiCAM - multiple rapid eye examination tests to screen for ophthalmological and neurological conditions
Benefits of our technology
- One combined perimeter, pupillograph and nystagmograph
- Early detection of ophthalmological and neurological conditions
- Provides objective data of functional eye examination
- Replaces manual examinations
- Patient does the work, not the clinician
- Improves accessibility
- Integrates with any third party ophthalmic device
The problems we solve
- Manually performing the entrance and functional eye examination
- Manually inserting test results
- Inefficient clinical workflow
- Subjective interpretation
- Lack of data during clinical decision making
- Lack of research data on eye - brain functionality
Our clinical importance
Dr. Bjørn Helland-Hansen introducing Bulbitech’s technology and explaining the importance of having one single device available in daily clinical practice that combines perimetry, pupillography and nystagmography.
Early detection of functional disorders with a dedicated platform and diagnostic device that replaces the manual examination and saves time
Decentralizing access to screening of ophthalmological and neurological conditions by introducing rapid eye examination tests
Rapid screening supports already understaffed eye care professionals to face an increase demand of eye care by providing them with a platform and diagnostic support device in which the patient does the work and can be operated by anyone
Generating objective data and clinical results to improve health outcome and research
BulbiCAM
One diagnostic device integrating perimetry, pupillography and nystagmography
- 600 FPS eyetracking
- Two screens for independent presentation to each eye
- Accurate timing synchronization
- Calibration free eye tracking test setup
- Individual compensation of refractive errors and head shape
- Can be operated remotely via internet
- CE-certified & FDA registered
Our solution
BulbiHUB platform
BulbiHUB platform assesses the data measured by BulbiCAM. BulbiHUB is an innovative point-of-care eye platform for the screening of ophthalmological and neurological disorders.
Telemedicine
Assessed data can be shared between and amongst clinical from peripheral locations to one central location, resulting in a clinical workflow that can continue remotely during pandemic outbreaks
AI [Artificial Intelligence]
Algorithms can be developed
to detect early stage neuro-
ocular dysfunctions and
analyze our collected data for research purpose
Our company
Our Timeline
2015
Funding from public funds and private investors for technology development
2016
Technical R&D development on platform & hardware
2017
Company & software CE-certified
Funding from public funds and private investors to complete smaller prototype
2019
Finalist in the DNB Healthcare prize
2020
Bulbitech wins healthcare pitching contest at Oslo Innovation Week
Certified QMS according to ISO 13485
Hardware CE-certified
2021
Bulbitech is FDA registered under number D437315